Immix Biopharma, Inc.
IMMX
$2.00
-$0.12-5.66%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -50.76% | 13.62% | 5.45% | -67.01% | -22.84% |
| Total Depreciation and Amortization | 228.40% | 147.70% | 1,232.26% | 1,750.00% | 4,760.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -14.83% | -0.32% | -28.35% | 8.86% | 46.79% |
| Change in Net Operating Assets | 146.33% | 259.30% | 81.80% | 353.92% | -313.99% |
| Cash from Operations | -1.02% | 55.97% | 44.86% | -30.76% | -49.52% |
| Capital Expenditure | -31.41% | 77.58% | -3,742.42% | -597.94% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -31.41% | 77.58% | -3,742.42% | -597.94% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -100.00% | -100.00% | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -100.00% | -100.00% | -100.00% |
| Foreign Exchange rate Adjustments | 395.51% | 23.08% | -180.19% | 294.92% | -36.88% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 19.85% | -114.91% | 3.09% | -161.84% | -548.90% |